Funding Alerts

The Texas Department of State Health Services Funding Information Center

Public Funding Opportunities

 

CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health: W81XWH-20-PRMRP-CTA-COV

SOURCE: U.S. Department of the Army – CDMRP (Congressionally Directed Medical Research Programs)

APPLICATION DEADLINE: Pre-Application Submission Deadline: 6/8/20 by 5 p.m. ET. Application Deadline: 6/22/20.

$ AVAILABLE: $30 million for five awards.

ELIGIBILITY: Unrestricted.

PURPOSE: The PRMRP (Peer Reviewed Medical Research Program) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact in one or more of the Focus Areas published in this funding opportunity for the FY20 PRMRP Congressionally specified Topic Areas of Emerging Viral Diseases and Respiratory Health. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0), to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.

Funding for this award mechanism must support a clinical trial and cannot be used for animal studies.

CFDA: 12.420

CONTACT: CDMRP Help Desk. Phone: (301) 682-5507. Email:mhelp@eBRAP.org. For more information, go to

www.grants.gov/web/grants/view-opportunity.html?oppId=326173.

From Grants.gov website, accessed 4/24/20.

Subject(s): medical research.

 

CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health: W81XWH-20-PRMRP-TTDA-COV

SOURCE: U.S. Department of the Army – CDMRP (Congressionally Directed Medical Research Programs)

APPLICATION DEADLINE: Pre-Application Submission Deadline: 5/28/20 by 5 p.m. ET. Application Deadline: 6/12/20.

$ AVAILABLE: $25 million for four awards.

ELIGIBILITY: Unrestricted.

PURPOSE: The PRMRP (Peer Reviewed Medical Research Program) Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications in one or more Focus Areas published in this funding opportunity for the FY20 PRMRP Topic Areas of Emerging Viral Diseases and/or Respiratory Health. Products in development should be responsive to the healthcare needs of military service members, veterans, and/or beneficiaries.

CFDA: 12.420

CONTACT: CDMRP Help Desk. Phone: (301) 682-5507. Email:help@eBRAP.org. For more information, go to www.grants.gov/web/grants/view-opportunity.html?oppId=326175.

From Grants.gov website, accessed 4/28/20.

Subject(s): medical research, technology.

 

Distance Learning and Telemedicine Grants: RUS-20-02-DLT

SOURCE: U.S. Department of Agriculture (USDA)

APPLICATION DEADLINE: 7/13/20.

$ AVAILABLE: The Rural Utilities Service (RUS), an agency of the United States Department of Agriculture, is announcing a new Distance Learning and Telemedicine (DLT) filing window, Window 2. Approximately $25 million, in addition to any available funds not awarded from Window 1, is available for funding opportunities under this Funding Opportunity Announcement (FOA). The agency reserves the right to increase funding utilizing the application queue under this FOA should additional appropriations become available for the same purposes.

ELIGIBILITY: Any of the following entities –

* Incorporated organization.

* Indian tribe or tribal organization, as defined in 25 U.S.C. 5304.

* State or local unit of government.

* Consortium as defined in 1734.3.

* Other legal entity, including a private corporation organized on a for profit or not-for-profit basis.

PURPOSE: The agency is providing this additional filing window for those that could not complete applications prior to the Window 1 deadline. This window also makes available up to $25 million received from the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). While the CARES Act requires these funds be used to prevent, prepare for, and respond to coronavirus, the agency believes that all DLT projects already serve that purpose. As a result, while not required, applicants are encouraged to identify specific ways in which their application addresses COVID-19. Authorized by 7 U.S.C. 950aaa, the DLT Program provides financial assistance to enable and improve distance learning and telemedicine services in rural areas. DLT grant funds support the use of telecommunications-enabled information, audio and video equipment, and related advanced technologies by students, teachers, medical professionals, and rural residents. These grants are intended to increase rural access to education, training, and health care resources that are otherwise unavailable or limited in scope.

The regulation for the DLT Program can be found at 7 CFR part 1734. All applicants should carefully review and prepare their applications according
to instructions in the FY 2020 DLT Grant Program Application Guide and program resources.       

CFDA: 10.855

CONTACT: Jose P. De Leon. Phone: (512) 809-8524 or (512) 288-5820.
Email: jose.deleon@usda.gov. For more information, go to www.rd.usda.gov/programs-services/distance-learning-telemedicine-grants.

From Grants.gov website, accessed 4/15/20.

Subject(s): telemedicine, disaster assistance.

 

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional): PA-20-135

SOURCE: National Institutes of Health (NIH)

APPLICATION DEADLINE: Please see URL for more information.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –
* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: The National Institutes of Health hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster.

Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA (Notice of Award) of the most recent parent award.

Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC (Institute and Center) will be allowed to apply to this funding opportunity announcement (FOA).

CFDA: 93.213; 93.393, 93.394, 93.395, 93.396, 93.399; 93.172; 93.855; 93.865; 93.847; 93.113; 93.142, 93.143; 93.859; 93.307; 93.286; 93.350; 93.273; 93.310    

CONTACT: Application Submission Contacts –

  • eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues).
  • Finding Help Online: grants.nih.gov/support/ (preferred method of contact); Telephone: 301-402-7469 or 866-504-9552 (Toll Free).
  • General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources) –
    Email: GrantsInfo@nih.gov (preferred method of contact);
    Telephone: 301-945-7573.
  • Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace) – Contact Center Telephone: 800-518-4726; Email: support@grants.gov.

For more information, go to grants.nih.gov/grants/guide/pa-files/PA-20-135.html.

From Grants.gov website, accessed 3/18/20.

Subject(s): medical research, disaster assistance.

 

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA: NOT-AA-20-011

SOURCE: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

APPLICATION DEADLINE: Applications will be accepted on a rolling basis through April 15, 2021 by 5 p.m. local time of the applicant organization.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –
* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: The impact of the COVID-19 pandemic on the nation is vast, especially on health and well-being. Research suggests that alcohol consumption tends to increase during times of duress and uncertainty such as disasters and other traumatic events, and as such alcohol is often misused to cope with stress, anxiety, and other uncomfortable emotions. In addition, the misuse of alcohol to cope with the stress as a result of physical distancing and other policy measures, and a lack of access to supportive social networks and treatment for people with pre-existing alcohol use disorder (AUD) are significant concerns during the pandemic. These outcomes are particularly challenging with respect to COVID-19 because alcohol misuse can interfere with normal immune system function and elevate susceptibility to viral infections of the respiratory system. Alcohol-associated damage to the liver, heart, and other organs may also complicate health outcomes in individuals with COVID-19. These myriad physical and behavioral health outcomes related to alcohol and COVID-19 present a range of urgent research needs and opportunities.

Research is needed to understand the potentially complex relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic. The outcomes include overt pathophysiology and the impact of social and policy measures on COVID-19 outcomes. Such studies also will help to lay the groundwork for responding to future public health emergencies. This NOSI encourages applications, in the form of urgent competitive revisions and administrative supplements to existing grants and cooperative agreements, to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.

NIAAA is encouraging research in the following areas, including those that capitalize on existing research cohorts, to investigate urgent research questions of significance to the COVID-19 pandemic within the general population and among underserved populations, such as racial, ethnic and gender minorities, individuals with low socioeconomic status, and those who are incarcerated or homeless.

CFDA: Please go to grants.nih.gov/grants/guide/notice-files/not-aa-20-011.html for CFDAs of related announcements.

CONTACT: Kathy Jung, PhD. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Telephone: 301-443-8744. Email:jungma@mail.nih.gov.

For more information, go to grants.nih.gov/grants/guide/notice-files/not-aa-20-011.html.

From Grants.gov website, accessed 4/24/20.

Subject(s): disaster assistance, substance abuse.

 

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19): NOT-LM-20-010

SOURCE: National Library of Medicine (NLM)

APPLICATION DEADLINE: 6/1/20.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –

* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: NLM is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NLM’s strategic goal of fostering data driven research.

Research Objectives: In order to rapidly improve our understanding of the infection of SARS-CoV-2 and of COVID-19, NLM is encouraging the submission of applications for administrative supplements to active NLM R01 grants to address the following research areas of interest:

* Methods for mining clinical data that can be used to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics such as discovery of risks for infection by SARS-Cov-2 viruses, use of standard terminologies for these viruses in federated health data sets

* Public health surveillance methods that mine genomic, viromic, health data, environmental data and/or data from other pertinent sources such as social media, to identify spread and impact of SARS-Cov-2.

Applications are expected to focus on informatics and data science methods to help address the COVID-19 pandemic in a timely manner. Applications that are not responsive will be withdrawn without review

CFDA: Please go to grants.nih.gov/grants/guide/notice-files/not-lm-20-010.html for CFDAs of related announcements.

CONTACT: Scientific/Research Contact – Hua-Chuan Sim, MD. National Library of Medicine (NLM). Telephone: 301-594-4882. Email:simh@mail.nih.gov; Financial/Grants Management Contact – Samantha Tempchin. National Library of Medicine (NLM). Telephone: 301-496-4221.

Email: tempchins@mail.nih.gov.

For more information, go to grants.nih.gov/grants/guide/notice-files/not-lm-20-010.html.

From Grants.gov website, accessed 4/29/20.

Subject(s): medical research, health information.

 

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences: NOT-OD-20-097

SOURCE: Office of Behavioral and Social Sciences Research (OBSSR)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) – New participating organization as of 04/17/2020 for due dates on/after 04/17/2020

National Institute of Nursing Research (NINR) – New participating organization as of 04/23/2020 for due dates on/after 04/23/2020.

APPLICATION DEADLINE: Applications will be accepted on a rolling basis through 3/31/21 by 5 p.m. local time of the applicant organization.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –

* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.

CFDA: Please go to grants.nih.gov/grants/guide/notice-files/not-od-20-097.html for CFDAs of related announcements.

CONTACT: Erica L. Spotts, PhD. Office of Behavioral and Social Sciences Research (OBSSR). Telephone: 301-594-2105. Email: spottse@mail.nih.gov.

Rebekah S. Rasooly, PhD. National Institute of Nursing Research. Telephone: 301-827-2599. Email: rr185i@nih.gov.

For more information, go to grants.nih.gov/grants/guide/notice-files/not-od-20-097.html.

From Grants.gov website, accessed 4/24/20.

Subject(s): medical research.

 

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19): NOT-EB-20-008

SOURCE: National Institute of Biomedical Imaging and Bioengineering (NIBIB)

APPLICATION DEADLINE: Applications will be accepted immediately and on a rolling basis through 11/10/20 by 5 p.m. local time of the applicant organization.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –

* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: The NIBIB is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years. Example technologies include, but are not limited to:

* Rapid point-of-care and home-based testing/diagnostics.

* Wearable, implantable, and remote sensors/imagers for physiological monitoring.

* Medical imaging technologies and algorithms/artificial intelligence (AI) for rapid detection, diagnosis, and monitoring of lung infection.

* Non-contact sensing and imaging for rapid mass screening and vital sign assessment.

* Digital health platforms and models that integrate data, assess risk, and provide illness surveillance and management tools.

* Technologies (including simulation platforms) for training healthcare workers and optimizing clinical workflows.

* Robotic and automation technologies to limit caregivers’ exposure and/or reduce burden on the healthcare system.

* Technologies for protecting healthcare workers, first responders, and caregivers.

* Oxygenation systems (e.g. ECMO, ventilators, intubation) and components designed for rapid deployment, access, and potential operation by minimally trained personnel.

* High-confidence disinfection technologies.

* Novel therapeutic strategies using engineered biological systems, including cell-based and synthetic biology technologies.

CFDA: Please go to /grants.nih.gov/grants/guide/notice-files/not-eb-20-008.html for CFDAs of related announcements.

CONTACT: Please contact the program officer on guide your active award.

For more information, go to grants.nih.gov/grants/ /notice-files/not-eb-20-008.html.

From Grants.gov website, accessed 4/24/20.

Subject(s): medical research, disaster assistance, technology.

 

Supporting Tribal Public Health Capacity in Coronavirus Preparedness and Response: CDC-RFA-OT20-2004

SOURCE: Centers for Disease Control and Prevention (CDC) – OSTLTS
(Office for State, Tribal, Local and Territorial Support)

APPLICATION DEADLINE: 6/31/20.

$ AVAILABLE: $40 million.

ELIGIBILITY: Indian/Native American tribal governments and organizations (federally recognized and other than federally recognized).

PURPOSE: On March 6, 2020, the President signed into law the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123). This act provides funding to prevent, prepare for, and respond to Coronavirus Disease 2019 (COVID-19). To support tribal public health emergency response to COVID-19, the Centers for Disease Control and Prevention is announcing a new, non-competitive grant CDC-RFA-OT20-2004 Supporting Tribal Public Health Capacity in Coronavirus Preparedness and Response. CDC is awarding at least $40,000,000 under this funding opportunity to Title I and Title V tribal nations to strengthen the tribal public health system to carry out surveillance, epidemiology, laboratory capacity, infection control, mitigation, communications, and other preparedness and response activities in response to COVID-19. CDC is committed to helping ensure that tribal jurisdictions have adequate resources for an appropriate COVID-19 response. The continued support for and expansion of critical public health activities at the tribal level are essential to meet the needs in this quickly evolving response. Funds from this funding opportunity will be made available for a variety of activities including, but not limited to:

* Emergency operations and coordination activities (e.g., establishing emergency operations centers, incident management systems, continuity
of operations plans, etc.);

* Public health management and risk assessment of travelers and others with potential COVID-19 exposure; equipment, supplies, shipping activities, or others to strengthen jurisdictional recovery;
* Laboratory, surveillance, and epidemiologic (e.g., case identification) activities, data management activities, and others to strengthen bio surveillance;

* Risk communications activities, distribution and use of medical material, and others to strengthen information management;

* Activities to strengthen countermeasures and mitigation (e.g., storage and distribution systems, inventory management systems, points of dispensing (POD) alternative nodes, etc.;

* Surge staffing activities, infection control activities and others to strengthen surge management; and Other preparedness and response activities.

CFDA: 93.391

CONTACT: Mitch Morris. Email: mhm9@cdc.gov. For more information, go to  www.grants.gov/web/grants/view-opportunity.html?oppId=325942.

From Grants.gov website, accessed 4/24/20.

Subject(s): health care services, disaster assistance.

 

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional): PA-18-935

SOURCE: National Institutes of Health (NIH)

APPLICATION DEADLINE: Please see URL for more information.

$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

ELIGIBILITY: Any of the following entities –

* Public/state/private controlled institutions of higher education.

* Hispanic-serving institutions.

* Historically Black Colleges and Universities (HBCUs).

* Tribally Controlled Colleges and Universities (TCCUs).

* Alaska native and native Hawaiian serving institutions.

* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).

* Small businesses.

* For-profit organizations (other than small businesses).

* State governments.

* County governments.

* City or township governments.

* Special district governments.

* Indian/Native American tribal governments (federally recognized and other than federally recognized).

* Eligible agencies of the federal government.

* U.S. territories or possessions.

* Independent school districts.

* Public housing authorities/Indian housing authorities.

* Native American tribal organizations (other than federally recognized tribal governments).

* Faith-based or community-based organizations.

* Regional organizations.

* Non-domestic (non-U.S.) entities (foreign institutions).

PURPOSE: The National Institutes of Health hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA (Notice of Award) of the most recent parent award.
Only applications submitted in response to an Urgent Guide Notice published by an IC (Institute and Center) will be allowed to apply to this FOA. 

CFDA: 93.866; 93.855; 93.279; 93.847; 93.242, 93.113, 93.272, 93.286, 93.172, 93.307, 93.350, 93.173

CONTACT: General Grants Information (Questions regarding application processes and NIH grant resources) – Email: GrantsInfo@nih.gov. (preferred method of contact). Telephone: 301-945-7573.
For additional contact and general information, go to  grants.nih.gov/grants/guide/pa-files/pa-18-935.html.

From Grants.gov website, accessed 3/17/20.

Subject(s): medical research, disaster assistance.

 

                          

Private Funding Opportunities

 

COVID-19 AWS Diagnostic Development Initiative (DDI)

SOURCE: Amazon Web Services (AWS)

APPLICATION DEADLINE: Applications will be accepted on a rolling basis until 6/30/20.

$ AVAILABLE: We are committing $20 million over the next year to accelerate research, innovation, and development to speed our collective understanding and detection of COVID-19 and other innovate diagnostic solutions to mitigate future infectious disease outbreaks. Funding will be provided through a combination of AWS in-kind credits and technical support to assist our customers’ research teams in harnessing the full potential of the cloud to tackle this challenge.

ELIGIBILITY: The program is open to accredited research institutions, research consortia, and private entities that are AWS customers. Individuals who apply must apply on behalf of their organization and not in their personal capacity.

PURPOSE: The Amazon Web Services (AWS) Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to
be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

CONTACT: Please go to AWS website for complete contact information.

For see more information, go to aws.amazon.com/government-education/nonprofits/disaster-response/diagnostic-dev-initiative/.

From Amazon Web Services website, accessed 4/17/20.

Subject(s): technology, medical research.

 

COVID-19 Relief in a State of Emergency (RISE) Fund

SOURCE: Austin Public Health

APPLICATION DEADLINE: Until $15 million allocation is exhausted.

$ AVAILABLE: $15 million.

ELIGIBILITY: Qualified social services agencies with demonstrated experience providing community-based services and financial assistance.

PURPOSE: Interventions must be designed to provide immediate direct services and assistance that are equitably focused and temporary for vulnerable residents, to quickly aid individuals affected by COVID-19.

CONTACT: Email: RISEFunding@AustinTexas.gov. For more information, go towww.austintexas.gov/article/covid-19-relief-state-emergency-rise-fund.

From City of Austin website, accessed 4/30/20.

Subject(s): disaster assistance.

 

COVID-19 Response Fund for Nonprofits Only

SOURCE: San Antonio Area Foundation

APPLICATION DEADLINE: Grants will be awarded on an as-needed basis.
The application will be available beginning March 20, 2020. At any time after that, you may access, save, complete, and submit the application. There is no deadline. Applications will be processed upon receipt Monday through Friday.

$ AVAILABLE: Please see URL for more information.

ELIGIBILITY: Grant funding is available to 501(c)(3) nonprofit organizations in Bexar, Atascosa, Bandera, Comal, Guadalupe, Kendall, Medina, and Wilson counties.

PURPOSE: We are providing general operating grants to nonprofit organizations with deep roots in community and strong experience in serving populations in the following issue areas:

* Lack of health insurance and/or access to paid sick leave.

* Economic impact of reduced and lost work.

* Immediate needs of economically vulnerable population caused by COVID-19 related closures.

* Increased demand for medical information and support due to fear and confusion among the most vulnerable residents.

* Assistance with funding that can be used for food supplies, prescriptions/medical that is not covered by insurance, emergency shelter, and cleanup of the disaster.

CONTACT: Email: covid19@saafdn.org. For more information, go towww.saafdn.org/Nonprofits/Grants/COVID-19-Response-Fund#1168602-additional-information.

From San Antonio Area Foundation website, accessed 3/25/20.

Subject(s): disaster assistance.

 

North Texas Cares

SOURCE: North Texas Funders Collaborative for COVID-19

APPLICATION DEADLINE: Rolling deadline.

$ AVAILABLE: Grant funding ranges vary. Average grants will range from $5,000 – $40,000.

ELIGIBILITY: Applicants must be a 501(c)3 organization serving North Texas and mustprovide services that address immediate response or long-term relief efforts in response to COVID-19. Requests need to focus on first responders and/or support for vulnerable populations (examples could include seniors, children, homeless, low-income displaced workers, first responders, medical professionals, and those without other resources), efforts that overtly address racial disparities, including efforts to address viral racism related to COVID-19, and efforts that address the racial disparities in communities of color that take into account areas such as access to care, food insecurities, and health disparities.

PURPOSE: North Texas Cares is a funder collaborative made up of North Texas foundations and United Ways that have come together to provide support for organizations that work with people and communities who may be most negatively affected by COVID-19.

CONTACT: Email: uwmdcommunityimpact@unitedwaydallas.org or grants@cfttexas.org. For more information, go to www.northtexascares.org/.

From North Texas Cares website, accessed 4/24/20.

Subject(s): disaster assistance.

 

Novartis COVID-19 Community Response Fund

SOURCE: Novartis U.S. Foundation

APPLICATION DEADLINE: Go to www.novartis.us/news/novartis-us-covid-19-initiatives for information on application deadline.

$ AVAILABLE: Grants will range between $100,000 and $250,000 for a one-year project period.

ELIGIBILITY: Applicants must be 501(c)(3) nonprofit organizations. Priority will be given to areas where Novartis has a physical presence and where there is an acute need, including, but not limited to, NJ, MA, CA, IL, NC, and NY.

PURPOSE: The Novartis COVID-19 Community Response Fund provides grants to support local initiatives and communities in the United States impacted by the COVID-19 outbreak.

Grants will support one or more of the objectives:

*Strengthening local and national healthcare infrastructure to meet increased demand and protect front line health workers.

*Establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare, and effective dissemination of important public health information.

*Creating or enhancing new community health programs specific to the pandemic response.

CONTACT: Please see URL for contact information. For more information, go towww.novartis.us/news/novartis-us-covid-19-initiatives.

From RHIHub This Week email, 4/16/20.

Subject(s): disaster assistance.

 

St. David’s Foundations Invites Applications from Frontline Nonprofits in Central Texas to the COVID-19 Recovery Fund

SOURCE: St. David’s Foundation

APPLICATION DEADLINE: 5/7/20, 8/13/20, and 10/15/20. Applications must be submitted by 3 p.m. CT. 

$ AVAILABLE: Please see URL for more information.

ELIGIBILITY: Nonprofits located in Bastrop, Caldwell, Hays, Travis, and Williamson Counties. Eligibility is open to 501(c)3 organizations within these five counties to support the immediate and intermediate needs of those working to improve health and support members of the community during this time of crisis.

PURPOSE: The fund will provide grants in support of frontline nonprofits working to provide emergency assistance to those impacted by COVID-19 in Central Texas’ most vulnerable communities.

The fund is designed to complement the efforts of local health departments, public health officials, and federal subsidies while expanding local capacity to address aspects of the outbreak as quickly and efficiently as possible. Beyond the immediate needs facing communities in the region, the foundation believes the crisis has created an extraordinary opportunity for greater and more equal health justice in Central Texas and is committed to partnering with its neighbors during the crisis.

Priority populations for the fund include older adults at risk of social isolation, women, children, and vulnerable populations, with special attention given to rural areas. The fund also will prioritize work that is related to factors that directly impact health and well-being, including telehealth, mental health, and youth-serving organizations. Direct service providers, such as those supporting essential healthcare, human services, and food insecurity directly connected to COVID-19, are vital to the recovery effort and will be considered for funding through the initiative.

CONTACT: Email: sdfrecoveryfund@stdavidsfoundation.org. For more information, go to stdavidsfoundation.org/covid19-recovery-fund/.

From Philanthropy News Digest email, 4/10/20.

Subject(s): disaster assistance.

 

Open Road Alliance Response to COVID-19

SOURCE: Open Road Alliance

APPLICATION DEADLINE: Applications accepted on a rolling basis.

$ AVAILABLE: One-time cash need of up to $100,000.

ELIGIBILITY: We only make a grant to an organization that is:

(1) otherwise fully funded, then

(2) hit an unexpected, external roadblock (i.e., COVID-19), where

(3) Open Road’s grant can fully solve the problem at hand and

(4) demonstrate the potential to create catalytic impact.

In this time of exceptional need, we will be prioritizing impact.

PURPOSE: This grant opportunity is for organizations engaging in direct COVID-19 response. We will prioritize organizations and activities that have a clear and direct role in ‘flattening the curve’ and thus limiting, shortening, or minimizing the economic and social, as well as health effects of the pandemic. Slowing and stopping the spread of COVID-19 is directly linked to reducing and limiting the economic and social hardship our communities are experiencing.

CONTACT: Email: funding@openroadalliance.org. For more information, go toopenroadalliance.org/covid-19/.

From Open Road Alliance website, accessed 4/27/20.

Subject(s): disaster assistance.

 

Wells Fargo Foundation COVID-19 Community Relief Efforts

APPLICATION DEADLINE: For more information, go to newsroom.wf.com/press-release/corporate-and-financial/wells-fargo-announces-aid-customers-and-communities-impacted.

$ AVAILABLE: Wells Fargo is donating $175 million to help address public health needs, small business, housing, and financial stability for the most vulnerable populations.

ELIGIBILITY: Eligible organizations must have tax exempt status under IRS code 501(c)(3), or be a qualified governmental agency, tribal entity, or public school or school system. They must demonstrate fiscal and administrative stability; deliver services through one of our focus areas; show broad community support; address specific community needs and be located in an eligible county. Applicants must be from a county where Wells Fargo does business. For more information, go to www.wellsfargo.com/about/corporate-responsibility/community-giving/local/.

PURPOSE: We are deploying resources to help address immediate and longer-term needs for shelter, rental assistance, housing, small business support and financial stability. While we are providing additional flexibility in our grant making to help nonprofits address operations, staffing costs and other urgent necessities, we continue to focus on supporting organizations that are strategically aligned with our funding priorities: housing affordability, small business growth, and financial health.

CONTACT: Please see URL for contact information. For more information, go towww.wellsfargo.com/about/ community corporate-responsibility/ -giving/giving-faqs/.

From Wells Fargo Foundation website accessed, 4/29/20.

Subject(s): disaster assistance.

  • The Texas Department of State Health Services Funding Information Center